BVS Bioventus Inc.

Bioventus is a global medical device company focused on developing and commercializing clinically differentiated, cost efficient and minimally invasive treatments that engage and enhance the body’s natural healing process. We believe our non-invasive medical device and biologic products play a critical role in supporting the body’s own healing mechanisms to heal or eliminate the pain caused by orthopedic conditions and problems, which we define as our active healing products.

$12.37  -0.23 (-1.83%)
As of 12/03/2021 15:59:57 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  USA
Country of incorporation:  USA
IPO date:  12/04/2014
Outstanding shares:  59,438,082
Average volume:  479,439
Market cap:   $748,919,833
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    09075A108
ISIN:        US09075A1088
Sedol:      BD6P6L2
Valuation   (See tab for details)
PE ratio:   36.33
PB ratio:   3.33
PS ratio:   1.88
Return on equity:   14.76%
Net income %:   5.64%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy